Banco De Sabadell, S.A Gilead Sciences, Inc. Transaction History

Banco De Sabadell, S.A

$136 Million
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $40,544 - $50,806	-700 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $47,383 - $51,121	700 New	700 $49,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $682,500 - $778,732	-11,375 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $63,731 - $72,618	1,125 Added 10.98%	11,375 $651,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $88,492 - $111,264	1,425 Added 16.15%	10,250 $643,000
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $245,956 - $285,600	3,400 Added 62.67%	8,825 $668,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.9 Million - $2.44 Million	-30,393 Reduced 84.85%	5,425 $407,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.91 Million - $2.1 Million	30,993 Added 642.34%	35,818 $2.33 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $2.52 Million - $2.78 Million	-40,356 Reduced 89.32%	4,825 $305,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $1.5 Million - $1.69 Million	-24,309 Reduced 34.98%	45,181 $3.05 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $450,591 - $504,780	7,206 Added 11.57%	69,490 $4.46 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $571,497 - $745,760	9,440 Added 17.86%	62,284 $3.88 Million
Q3 2018 Nov 16, 2018	SELL	$71.28 - $78.92 $1.4 Million - $1.55 Million	-19,650 Reduced 27.11%	52,844 $4.06 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $124,115 - $144,775	-1,913 Reduced 2.57%	72,494 $5.12 Million
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $1.38 Million - $1.68 Million	-18,934 Reduced 20.28%	74,407 $5.57 Million
Q4 2017 Feb 16, 2018	BUY	$71.15 - $83.52 $6.64 Million - $7.8 Million	93,341	93,341 $6.69 Million

Others Institutions Holding GILD

# of Institutions

1,902

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

Black Rock Inc. New York, NY

121M
Shares

$10.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.77 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.37 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.27 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account